Toward a better definition of the restless legs syndrome
✍ Scribed by Dr. Arthur S. Walters; Michael S. Aldrich; Richard Allen; Sonia Ancoli-Israel; David Buchholz; Sudhansu Chokroverty; Giorgio Coccagna; Christopher Earley; Bruce Ehrenberg; T. G. Feest; Wayne Hening; Neil Kavey; Gilles Lavigne; Joseph Lipinski; Elio Lugaresi; Pasquale Montagna; Jacques Montplaisir; Sarah S. Mosko; Wolfgang Oertel; Daniel Picchietti; Thomas Pollmächer; Renata Shafor; Robert C. Smith; Wenche Telstad; Claudia Trenkwalder; Christian von Scheele; Arthur S. Walters; J. Catesby Ware; Marco Zucconi
- Publisher
- John Wiley and Sons
- Year
- 1995
- Tongue
- English
- Weight
- 916 KB
- Volume
- 10
- Category
- Article
- ISSN
- 0885-3185
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
A large International Restless Legs Syndrome (RLS) Study Group has been formed. As its first task, the group has taken upon itself the role of definig the clinical features of the RLS. As minimal criteria for diagnosis, the group proposes the following four features: (a) desire to move the extremities, often associated with paresthesias/dysesthesias; (b) motor restlessness; (c) worsening of symptoms at rest with at least temporary relief by activity, and (d) worsening of symptoms in the evening or night. Other features commonly seen in RLS include sleep disturbance, periodic limb movements in sleep and similar involuntary movements while awake, a normal neurological examination in the idiopathic from, a tendency for the symptoms to be worse in middle to older age, and, in some cases, a family history suggestive of an autosomal dominant mode of inheritance.
📜 SIMILAR VOLUMES
Dopaminergic agents are the best-studied agents and are considered first-line treatment of restless legs syndrome (RLS). Extensive data are available for levodopa, pramipexole, and ropinirole, which have approval for the indication RLS, and to a smaller extent for cabergoline, pergolide, and rotigot
The impressive relief from restless legs syndrome (RLS) symptoms provided by levodopa treatment indicates RLS is caused by a dopaminergic abnormality. But similar and more lasting relief also occurs for iron treatment in some patients. Thus there are two major putative causes for RLS: CNS dopaminerg
The Restless Legs Syndrome (RLS) is a heterogeneous disease. Symptomatic or secondary forms encompass iron deficiency, uremia, pregnancy, polyneuropathy, and other causes. The so-called idiopathic RLS syndrome preferentially affects patients with a younger onset before the age of 30. Here we summari
## Abstract Iron deficiency anemia has been linked to restless legs syndrome (RLS) and regular blood donation may lead to iron deficiency. It has been reported that blood donations may be associated with RLS. A recent study from Sweden found that 25% of the women donors were affected by RLS. Howeve